CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $34,349
- in 1 filing
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Alland Leila Director | Sale | −11,000 | $5.92 | $65K | 162,614 |
| 2026-02-02 | Alland Leila Director | Sale | −18,065 | $5.09 | $92K | 173,614 |
| 2026-01-26 | Alland Leila Director | Grant or award | +37,313 | 191,679 | ||
| 2025-01-31 | Alland Leila Director | Grant or award | +36,101 | 154,366 | ||
| 2024-08-26 | Alland Leila Director | Grant or award | +11,797 | 118,265 | ||
| 2024-07-08 | Alland Leila Director | Grant or award | +23,611 | 106,468 | ||
| 2024-05-16 | Alland Leila Director | Purchase | +11,000 | $4.71 | $52K | 82,857 |
| 2023-09-27 | Alland Leila Director | Sale | −7,246 | $3.90 | $28K | 71,857 |
| 2023-06-14 | Alland Leila Director | Grant or award | +58,689 | $4.62 | $271K | 79,103 |
| 2022-09-26 | Alland Leila Director | Grant or award | +13,400 | 20,414 | ||
| 2021-05-25 | Alland Leila Director | Grant or award | +77,181 | 77,181 | ||
| 2021-05-25 | Alland Leila Director | Grant or award · Stock Option (right to buy) | +98,168 | 98,168 |
Page 1 of 1 · 12 trades